Kura Oncology Growth Metrics (2023-2026) | KURA

Growth Metrics Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -360.00
EBITDA Margin (QoQ) (Quarter) -2865.007,804.00-11043.005,744.00
EBIT Margin Growth (1y) (Quarter) 2,710.00
EBIT Margin (QoQ) (Quarter) 2,865.007,466.00149,619.00-157241.00
EBT Margin Growth (1y) (Quarter) 401.00
EBT Margin (QoQ) (Quarter) -2704.007,532.00149,609.00-154036.00
Enterprise Value Growth (1y) (Quarter) 3.20%-29.86%-3.05%-0.60%-71.57%-24.87%-28.32%-20.73%8.27%11.75%
Enterprise Value Growth (3y) (Quarter) -15.06%-12.69%
Enterprise Value (QoQ) (Quarter) 7.33%-17.51%5.11%6.33%-24.33%6.75%7.37%-59.76%9.51%4.17%12.85%-21.39%12.95%
FCF Margin Growth (1y) (Quarter) 4,115.00
FCF Margin (QoQ) (Quarter) 31,413.00-19213.00103,977.00-112062.00
Gross Margin Growth (1y) (Quarter) -143.00
Interest Coverage Ratio Growth (1y) (Quarter) -37.22%-35.34%-43.15%1,471.58%-38.49%
Interest Coverage Ratio (QoQ) (Quarter) -0.63%-5.50%68.20%-306.39%0.74%-11.59%404.73%-141.03%
Net Margin Growth (1y) (Quarter) 557.00
Net Margin (QoQ) (Quarter) -2544.007,532.00149,568.00-153999.00
Operating Margin Growth (1y) (Quarter) 2,710.00
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) 3,040.002,463.00
Return on Capital Employed (QoQ) (Quarter) 342.00-513.00-736.003,947.00-234.00
Return on Equity Growth (1y) (Quarter) 0.000.000.000.000.00
Return on Equity (QoQ) (Quarter) 0.000.000.000.000.000.001.000.00
Return on Sales Growth (1y) (Quarter) 0.00
Return on Sales (QoQ) (Quarter) 0.001.0015.00-15.00